US Patent Issued to Viking Therapeutics, Metabasis Therapeutics on Oct. 14 for "Use of thyroid beta-agonists" (American, Chinese Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,440,502, issued on Oct. 14, was assigned to Viking Therapeutics Inc. (San Diego) and Metabasis Therapeutics Inc. (San Diego).

"Use of thyroid beta-agonists" was invented by Brian Lian (San Diego), Rochelle Hanley (Ann Arbor, Mich.), Misha Dinerman (Cincinnati), Mark Erion (Brookline, Mass.), Serge Boyer (San Diego) and Hongjian Jiang (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods useful for treating X-linked adrenoleukodystrophy are provided."

The patent was filed on March 5, 2024, under Application No. 18/595,919.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?S...